000 | 01665 a2200457 4500 | ||
---|---|---|---|
005 | 20250515150222.0 | ||
264 | 0 | _c20090402 | |
008 | 200904s 0 0 eng d | ||
022 | _a1355-008X | ||
024 | 7 |
_a10.1007/s12020-008-9129-z _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhang, He-Yu | |
245 | 0 | 0 |
_aRUNX1 and RUNX2 upregulate Galectin-3 expression in human pituitary tumors. _h[electronic resource] |
260 |
_bEndocrine _cFeb 2009 |
||
300 |
_a101-11 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenoma _xgenetics |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCore Binding Factor Alpha 1 Subunit _xantagonists & inhibitors |
650 | 0 | 4 |
_aCore Binding Factor Alpha 2 Subunit _xantagonists & inhibitors |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 |
_aGalectin 3 _xgenetics |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
650 | 0 | 4 | _aHeLa Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPituitary Neoplasms _xgenetics |
650 | 0 | 4 | _aPromoter Regions, Genetic |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 |
_aRNA, Small Interfering _xpharmacology |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
700 | 1 | _aJin, Long | |
700 | 1 | _aStilling, Gail A | |
700 | 1 | _aRuebel, Katharina H | |
700 | 1 | _aCoonse, Kendra | |
700 | 1 | _aTanizaki, Yoshinori | |
700 | 1 | _aRaz, Avraham | |
700 | 1 | _aLloyd, Ricardo V | |
773 | 0 |
_tEndocrine _gvol. 35 _gno. 1 _gp. 101-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12020-008-9129-z _zAvailable from publisher's website |
999 |
_c18477538 _d18477538 |